Book List: pharmaceutical patent

Ribozyme successfully defends European patent.(Ribozyme Pharmaceuticals, Inc.)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Thesaurus of proprietary preparations and pharmaceutical specialties: Including "patent" medicines, proprietary pharmaceuticals, open-formula specialties, synthetic remedies, etc Author: A. Emil Hiss Publisher: G.P. Engelhard Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals.(Company overview): An article from: BIOTECH Patent News Offer Price: USD $9.95 Author: Gale Reference Team Publisher: Biotech Patent News Alexion and CuraGen establish drug target discovery alliance.(Alexion Pharmaceuticals)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Aventis says antitrust lawsuit is baseless.(Aventis Pharmaceuticals)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Former Vertex patent counsel sentenced to prison for insider trading.(Vertex Pharmaceuticals Inc.): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News The face of the patent is not the ''Whole Story'': determining effective life of a pharmaceutical patent in the United States [An article from: World Patent Information] Offer Price: USD $5.95 Author: A.M. Clark Publisher: Elsevier Pharmaceutical Patent Issues: Interpreting GATT: Hearings Before the Committee on the Judiciary, U.S. Senate Offer Price: USD $35.00 Publisher: Diane Pub. GPC Biotech and Ingenium receive joint drug discovery grant from German government.(Ingenium Pharmaceuticals AG): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Guide published for successful pharmaceutical patent writing.: An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News

Pharmaceutical Patent Law, 2009 Cumulative Supplement by John R. Thomas Offer Price: USD $520.00 Author: John R. Thomas Publisher: ABA Anti-angiogenic ribozyme patent issued to Ribozyme.(Ribozyme Pharmaceuticals)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Inkine Pharmaceutical announces issuance of patents for Fc receptor technology and Diacol.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News 3-Dimensional Pharmaceuticals receives important patent covering high-throughput screening technology.(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Bristol-Myers Squibb Medical Imaging and IMCOR Pharmaceutical enter into cross-licensing agreement for ultrasound contrast patents.(IMCOR Pharmaceutical Co.): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Pricing, patent loss and the market for pharmaceuticals.: An article from: Southern Economic Journal Offer Price: USD $5.95 Author: Richard G. Frank Publisher: Southern Economic Association Alnylam grants RNAx license to key patent in RNA interference.(German affiliate of Alnylam Pharmaceuticals, Inc., Ribopharma AG, grants RNAx GmbH license): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News OSI Pharmaceuticals licenses Cyanamid's yeast Gpcr technology in patent cross-licensing agreement.(G-protein coupled receptors)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Aventis licenses Sertanty kinase structure activity database.(Aventis Pharmaceuticals Inc.)(Sertanty Inc.): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News Idun granted key patent covering methods for the inhibition of programmed cell death.(Idun Pharmaceuticals Inc.)(Brief Article): An article from: BIOTECH Patent News Offer Price: USD $5.95 Publisher: Biotech Patent News